2008: American Heart Association Scientific Sessions:Podium Presentation: Resource Use and Costs of Heart Failure in Medicare Population, 2003-2005
2008: In Vitro Diagnostic Regulatory & Reimbursement Conference: Presentation: Closing the Gap Between Traditional Regulatory and Sales Projections, and Payer Uptake. Conference Website
2008: ABL Round Table Meeting: "How to Position for and Expedite Optimum Reimbursement and Coverage"
2008: Part B News:Four Steps to Boost Revenue with Clinical Trials
2008: Part B News:Four Steps to Boost Revenue with Clinical Trials
2008:Current Medical Research and Opinion: Economic Evaluation of Medication, Laser Trabeculoplasty, and Filtering Surgeries in Treating Patients with Glaucoma
2008:Clinical Therapeutics: Cost-Effectiveness Analysis of Antifungal Prophylaxis in Patients Undergoing Hematopoietic Stem Cell Transplantation
2007:The Ninth International Symposium on Myelodysplastic Syndromes Poster Presentation: Prevalance of Cardiac Disease among a US Medicare Population with Myelodysplastic Syndromes & Incidence of Myelodysplastic Sydroms in the United States Medicare Population
2008:International Stroke Conference Poster Presentation:Costs and Rehabilitation of Stroke Patients: A Retrospective Study of Medicare Beneficiaries
2006:ICAAC Conference Poster Presentation:Hospital Costs of Esophageal Candidiasis, The Economic Impact of Esophageal Candidiasis within Hospital Expenditures across patient subgroups
2007:Current Medical Research and Opinion: The Impact of Esophageal Candidiasis on Hospital Charges and Costs Across Subgroups
2007:Breast Cancer Symposium Poster Presentation: HER-2 Testing and Trastuzumab Use in the Medicare Population
2007:Journal of Drugs in Dermatology, New Methods and Techniques: A Multiple-Domain Framework of Clinical, Economic, and Patient-Reported Outcomes for Evaluating Benefits of Intervention in Atopic Dermatitis
2006:Journal of Heart and Lung Transplantation: Hospital costs for left-ventricular assist devices for destination therapy, Lower costs for implantation in the post-REMATCH era
2006:ISHAM Poster Presentation:Cost-Effectiveness Analysis of Anti-Fungal Prophylaxis in Patients Undergoing Hematopoietic Stem Cell Transplantation
2006:ASHP Poster Presentation:The Economic Impact of Aspergillosis: Analysis of Hospital Expenditures Across Patient Subgroups
2006:ASCO Poster Presentation:Incidence, Costs of Care, and Mortality of Medicare Beneficiaries Diagnosed with Cancer of Unknown Primary Origin
2005:ICAAC Poster Presentation:Cost Effectiveness Analysis of Combined Phenotype and Genotype Drug Resistance Testing versus Genotyping Alone
2005:NATCO Poster Presentation: Impact of Calcineurin Inhibitor on Side Effects and Mental Quality Of Life: Findings from The Patient Outcomes Registry For Transplant Effects On Life (PORTEL)
2005:PharmacoEconomics: The Economics of Topical Immunomodulators for the Treatment of Atopic Dermatitis
2005:ISPOR Poster Presentation: Frequency of INR Testing in Medicare Beneficiaries at High Risk for Stroke
2005:ISHLT Poster Presentation:Advances in Patient and Economic Outcomes Associated with Left Ventricular Assist Devices for Destination Therapy
2004:ISHLT Poster Presentation:Lower costs associated with home discharge of bridge-to-transplant patients using the TLC-II portable driver
2004:ISHLT Poster Presentation: The Effect of a Heart Assist Device Clinical Study on Hospital Referrals and Revenues
2004:ISHLT Poster Presentation: Longitudinal analysis of quality of life in kidney and liver patients in the Patient Outcomes Registry for Transplant Effects on Life (PORTEL)
2004:ITNS Oral Presentation: Quality of life and side effect profile of liver versus kidney recipients the first two years posttransplant: findings from the Patient Outcomes Registry for Transplant Effect on Life (PORTEL)
2004:Journal of Investigative Dermatology: Look Beyond Financial Conflicts of Interest in Evaluating Industry-Academia Collaborations in Burden-of-Illness and Outcomes Research Studies in Dermatology.
2004:NATCO Oral Presentation: Quality of life and side effect profile of liver versus kidney recipients the first two years posttransplant: findings from the Patient Outcomes Registry for Transplant Effect on Life (PORTEL)
2003:Clinical Infectious Diseases: Amphotericin B-related Nephrotoxicity has an Economic Impact on Hospitals and Health Systems.
2003:Infectious Diseases Society of America Poster Presentation:The Economic Impact of Aspergillosis: Analysis of Hospital Expenditures and Payer Reimbursements
2003:International Transplant Nurses Society 12th Annual Symposium Oral Presentation:Quality of Life and Side Effects in Kidney Transplant Patients Treated with Cyclosporine- and Tacrolimus-based Immunosuppressive Regimens
2003:Transplant Immunosuppression Conference Oral Presentation:Side Effects and Quality of Life in a Cohort of Recent Kidney Transplant Recipients
2003:Pharmacoeconomics: Validation of Expert Opinion in Identifying Comorbidities Associated with Atopic Dermatitis/Eczema.
2003:Clinical Transplantation: The first report from the Patient Outcomes Registry for Transplant Effects on Life (PORTEL), Differences in side-effects and quality of life by organ type, time since transplant and immunosuppressive regimens
2003:Progress in Transplantation: The PORTEL Registry, Overview and Selected Findings
2003:Progress in Transplantation: Assessing Quality-of-life Outcomes in Organ Transplant Recipients: Progress and Priorities
2003:Journal of the American Academy of Dermatology: Cost-Effectiveness Analysis of Tacrolimus Ointment Versus High-Potency Topical Corticosteroids in Adults with Moderate to Severe Atopic Dermatitis
2003:Biology of Blood and Marrow Transplantation: Pharmacoeconomics of Prophylaxis for Fungal Infections in Patients Undergoing a Hematopoietic Stem Cell Transplant
2003:British Journal of Dermatology: Prevalence of Hypertension Among Patients with Atopic Dermatitis
2002:American Heart Association Poster Presentation: Patterns and Outcomes of Care in the Emergency Treatment of Ischemic Stroke
2002:Journal of Medical Economics: Factors Associated with Increased Hospital Costs in Patients Treated with Lipid-based Amphotericin B for Empirical Therapy
2002:NATCO Poster Presentation: A Follow-up Report from the Patient Outcomes Registry for Transplant Effects on Life
2002:NATCO Oral Presentation: Predictors of Post-Transplant Quality of Life: A Follow-up Report from the Patient Outcomes Registry for Transplant Effects on Life
2002:Annales de Dermatologie et de Vénéréologie: Cost-Effectiveness Analysis of Tacrolimus Ointment and Topical Corticosteroids in Moderate to Severe Atopic Dermatitis.
2002:Annales de Dermatologie et de Vénéréologie: Payer Costs of Atopic Dermatitis and Eczema in Children in the United States.
2002:Quorum Consulting Newsletter: Reimbursement Capabilities
2002:American Transplant Congress Poster Presentation:Differences in Clinical Outcomes, Side Effects and Quality of Life in Patients Treated with Cyclosporine and Tacrolimus-based Immunosuppressive Regimens
2002:Journal of the American Academy of Dermatology: Cost of Atopic Dermatitis and Eczema in the United States
2002:Quorum Consulting Newsletter: Skin Conditions and New Treatments.
2001:Society for Investigative Dermatology Poster Presentation: Third-Party Payer Cost of Atopic Dermatitis and Eczema in the United States
2000:Journal of Clinical Oncology: Pharmacoeconomic Analysis of Liposomal Amphotericin B Versus Conventional Amphotericin B in the Empirical Treatment of Persistently Febrile Neutropenic Patients
Subscribe